4-AMINOPYRIDINE IMPROVES NEUROLOGICAL DEFICITS IN MULTIPLE-SCLEROSIS PATIENTS - DEMONSTRATION IN A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

被引：0
|
作者：
BEVER, CT
YOUNG, D
ANDERSON, P
KRUMHOLZ, A
CONWAY, K
LESLIE, J
EDDINGTON, N
PLAISANCE, K
PANITCH, H
JOHNSON, K
ROSENBERG, L
DEVANE, J
机构：
来源：
NEUROLOGY | 1992年 / 42卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1427 / 1427
页数：1
相关论文
共 50 条
  • [21] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, VARIABLE DOSAGE, COMPARATIVE THERAPEUTIC TRIAL OF AZATHIOPRINE WITH AND WITHOUT METHYLPREDNISOLONE IN MULTIPLE-SCLEROSIS
    ELLISON, GW
    MYERS, LW
    MICKEY, MR
    GRAVES, MC
    TOURTELLOTTE, WW
    SYNDULKO, K
    SHAPSHAK, P
    NUWER, MR
    PACKWOOD, JW
    FAHEY, JL
    SPINA, CA
    HOLEVOETHOWSON, MI
    LERNER, CD
    FRANE, MV
    PETTLERJENNINGS, P
    OSBORNE, MA
    BURGER, RL
    BEALL, T
    JEFFRYES, P
    NEUROLOGY, 1986, 36 (04) : 284 - 284
  • [22] 4-AMINOPYRIDINE IMPROVES CLINICAL SIGNS IN MULTIPLE-SCLEROSIS
    STEFOSKI, D
    DAVIS, FA
    TYSZKA, MF
    SCHAUF, CL
    ANNALS OF NEUROLOGY, 1985, 18 (01) : 131 - 131
  • [23] 4-AMINOPYRIDINE IMPROVES CLINICAL SIGNS IN MULTIPLE-SCLEROSIS
    STEFOSKI, D
    DAVIS, FA
    FAUT, M
    SCHAUF, CL
    ANNALS OF NEUROLOGY, 1987, 21 (01) : 71 - 77
  • [24] DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSSOVER TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN PATIENTS WITH CHRONIC PROGRESSIVE FORM OF MULTIPLE-SCLEROSIS
    CAZZATO, G
    MESIANO, T
    ANTONELLO, R
    MONTI, F
    CARRARO, N
    TORRE, P
    BOSCO, A
    CARGNELUTTI, D
    EUROPEAN NEUROLOGY, 1995, 35 (04) : 193 - 198
  • [25] A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis
    Romine, JS
    Sipe, JC
    Koziol, JA
    Zyroff, J
    Beutler, E
    PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (01) : 35 - 44
  • [26] Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
    Hawker, Kathleen
    O'Connor, Paul
    Freedman, Mark S.
    Calabresi, Peter A.
    Antel, Jack
    Simon, Jack
    Hauser, Stephen
    Waubant, Emmanuelle
    Vollmer, Timothy
    Panitch, Hillel
    Zhang, Jiameng
    Chin, Peter
    Smith, Craig H.
    ANNALS OF NEUROLOGY, 2009, 66 (04) : 460 - 471
  • [27] EFFECTS OF 4-AMINOPYRIDINE IN PATIENTS WITH MULTIPLE-SCLEROSIS
    JONES, RE
    HERON, JR
    FOSTER, DH
    SNELGAR, RS
    MASON, RJ
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1983, 60 (03) : 353 - 362
  • [28] Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial
    Kouchaki, Ebrahim
    Tamtaji, Omid Reza
    Salami, Mahmoud
    Bahmani, Fereshteh
    Kakhaki, Reza Daneshvar
    Akbari, Elmira
    Tajabadi-Ebrahimi, Maryam
    Jafari, Parvaneh
    Asemi, Zatollah
    CLINICAL NUTRITION, 2017, 36 (05) : 1245 - 1249
  • [29] Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
    Jessica Mandrioli
    Roberto D’Amico
    Elisabetta Zucchi
    Sara De Biasi
    Federico Banchelli
    Ilaria Martinelli
    Cecilia Simonini
    Domenico Lo Tartaro
    Roberto Vicini
    Nicola Fini
    Giulia Gianferrari
    Marcello Pinti
    Christian Lunetta
    Francesca Gerardi
    Claudia Tarlarini
    Letizia Mazzini
    Fabiola De Marchi
    Ada Scognamiglio
    Gianni Sorarù
    Andrea Fortuna
    Giuseppe Lauria
    Eleonora Dalla Bella
    Claudia Caponnetto
    Giuseppe Meo
    Adriano Chio
    Andrea Calvo
    Andrea Cossarizza
    Nature Communications, 14 (1)
  • [30] Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
    Mandrioli, Jessica
    D'Amico, Roberto
    Zucchi, Elisabetta
    De Biasi, Sara
    Banchelli, Federico
    Martinelli, Ilaria
    Simonini, Cecilia
    Lo Tartaro, Domenico
    Vicini, Roberto
    Fini, Nicola
    Gianferrari, Giulia
    Pinti, Marcello
    Lunetta, Christian
    Gerardi, Francesca
    Tarlarini, Claudia
    Mazzini, Letizia
    De Marchi, Fabiola
    Scognamiglio, Ada
    Soraru, Gianni
    Fortuna, Andrea
    Lauria, Giuseppe
    Dalla Bella, Eleonora
    Caponnetto, Claudia
    Meo, Giuseppe
    Chio, Adriano
    Calvo, Andrea
    Cossarizza, Andrea
    NATURE COMMUNICATIONS, 2023, 14 (01)
12345